Bioextrax AB (85X0) AI Stock Analysis

0 Followers

Bioextrax AB

(Frankfurt:85X0)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Debt-free balance sheetA debt-free balance sheet reduces refinancing exposure and interest obligations, giving Bioextrax greater flexibility while it develops its products. This structure can help preserve strategic options during periods of weak profitability, although ongoing losses still threaten capital strength.

Negative Factors

Very small, declining revenueSmall and declining revenue limits Bioextrax’s ability to absorb operating expenses and demonstrates that commercial scale has not yet been established. Continued contraction would make it harder to fund product development internally and could delay the transition toward a sustainable operating model.

Bioextrax AB (85X0) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 10.78M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -6.1
Beta (1Y): 0.78
Revenue Growth: -36.00%
EPS Growth: -2.34%
Country: Germany
Employees: 14
Sector: Industrials
Sector Strength: 63
Industry: Biotechnology

Bioextrax AB Business Overview & Revenue Model

Company Description

Bioextrax AB (publ) focuses on developing and commercializing a groundbreaking, biology-driven extraction system. This advanced technology facilitates the recovery of a variety of valuable materials from bacterial origins, such as bioplastic granules...

Bioextrax AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (63)

Financial Indicators

DE:85X0 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	63Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
SE:NXTCL	46Neutral	SEK 31.41M	-0.62	-81.23%	―	-4.02%	35.86%
SE:XINT	46Neutral	SEK 120.58M	-2.39	245.07%	―	-38.46%	9.02%
SE:ANNX	44Neutral	SEK 77.07M	-2.03	―	―	―	7.33%
SE:SPAGO	43Neutral	SEK 37.36M	-1.13	-87.37%	―	-97.52%	31.31%
SE:BIOVIC.B	41Neutral	SEK 93.57M	-1.24	-75.51%	―	56.06%	63.95%

* Industrials Sector Average

Performance Comparison

DE:85X0 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:85X0	Bioextrax AB	0.22	0.04	22.73%
SE:XINT	Xintela AB	0.14	-0.13	-47.96%
SE:BIOVIC.B	Biovica International AB Class B	0.31	-0.24	-44.20%
SE:NXTCL	NextCell Pharma AB	0.24	-0.56	-70.03%
SE:SPAGO	Spago Nanomedical AB	0.04	-0.07	-59.82%
SE:ANNX	Annexin Pharmaceuticals AB	8.94	-16.08	-64.27%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Bioextrax AB AI Stock Analysis